How Using Real-world Data can Optimize Treatment and Outcomes for Patients with Glaucoma
![Verana-White-Paper---Sight-Sciences_Banner Verana-White-Paper---Sight-Sciences_Banner](https://info.veranahealth.com/hs-fs/hubfs/Verana-White-Paper---Sight-Sciences_Banner.png?width=601&height=145&name=Verana-White-Paper---Sight-Sciences_Banner.png)
Access Your Copy of the White Paper
Verana Health and Sight Sciences collaborated to review the patient outcomes data from the FDA cleared ab-interno MIGS devices leveraging the IRIS®️ Registry (Intelligent Research in Sight)
![Verana_White_Paper_-_Sight_Sciences_Cover Verana_White_Paper_-_Sight_Sciences_Cover](https://info.veranahealth.com/hs-fs/hubfs/Verana_White_Paper_-_Sight_Sciences_Cover.png?width=250&height=324&name=Verana_White_Paper_-_Sight_Sciences_Cover.png)
This white paper includes:
-
Details on the MIGS landscape
-
How using real-world data can reveal the true efficacy of MIGS
-
Case study in collaboration with Sight Sciences
Complete the form to access your copy.
Please do not send any Protected Health Information (PHI) when submitting this form. This form is not encrypted and it is not a suitable method for transmitting PHI. Any PHI sent to Verana Health via this form is deemed to be authorized by the subject of the PHI.
![Dots Divider Dots Divider](https://info.veranahealth.com/hubfs/Dots/Dots%20Divider.png)